Sarepta Therapeutics: Q3 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $40.9 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 46 cents per share.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.66 per share.
The biopharmaceutical company posted revenue of $331.8 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $286.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT
